Clinical Trial Update: Bioequivalence Study of an Amoxicillin-Clavulanic [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of amoxicillin-clavulanic acid has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Amoxicillin-Clavulanic (amoxicillin/clavulanic acid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 1 | Status: COMPLETED